Biodistribution of <sup>10</sup>B in Glioma Orthotopic Xenograft Mouse Model after Injection of L-para-Boronophenylalanine and Sodium Borocaptate
Boron neutron capture therapy (BNCT) is based on the ability of the boron-10 (<sup>10</sup>B) isotope to capture epithermal neutrons, as a result of which the isotope becomes unstable and decays into kinetically active elements that destroy cells where the nuclear reaction has occurred....
Main Authors: | Natalya V. Gubanova, Alphiya R. Tsygankova, Evgenii L. Zavjalov, Alexander V. Romashchenko, Yuriy L. Orlov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/7/722 |
Similar Items
-
Dose-Dependent Suppression of Human Glioblastoma Xenograft Growth by Accelerator-Based Boron Neutron Capture Therapy with Simultaneous Use of Two Boron-Containing Compounds
by: Vladimir Kanygin, et al.
Published: (2021-11-01) -
Boron Neutron Capture Therapy - A Literature Review
by: Kavitaa Nedunchezhian, et al.
Published: (2016-12-01) -
Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with <sup>10</sup>B-Borocaptate Sodium (BSH) and <sup>10</sup>B-Paraboronophenylalanine (BPA)
by: Hiroshi Fukuda
Published: (2021-10-01) -
Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using <sup>10</sup>B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
by: Hiroshi Fukuda
Published: (2021-10-01) -
The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
by: Yusuke Fukuo, et al.
Published: (2020-12-01)